Please find below some urgent information from our sponsor, Golden Opportunities.
The RoyalRoyalty Play
In a mining sector where royalty companies seem to be popping up everywhere, Empress Royalty (EMPR.V; EMPYF.OTCQX) boasts key advantages that separate it from all the others.
Here’s why top investors like one of the world’s leading bullion dealers (Money Metals CEO Stefan Gleason) AND Rick Rule are focused on this “royal royalty play.”
Watch here:
Dear Reader,
With both gold and silver breaking out again, smart investors are rushing into physical bullion… but also mining royalty companies.
And for good reason…
Royalty companies offer tremendous leverage to rising metals prices — and with typically much lower risk than individual mining stocks.
And this is why there are now lots of royalty companies out there vying for investor interest, making it difficult to find the cream of the crop.
These facts about Empress Royalty (EMPR.V; EMPYF.OTCQX) will help:
Significant revenue… and a track record of doubling it
An expanding royalty portfolio — and all of it in precious metals
Still substantially undervalued — trading at a 60% discount to industry average price/cash flow
As compelling as those facts may be, there are other powerful factors that also put Empress Royalty over the top for smart investors like Rick Rule and Stefan Gleason (CEO of Money Metals, one of the world’s top bullion dealers and storage firms).
They talk about those key factors for Empress — along with why they feel we’ve entered a major gold and silver bull market will rival that of the 1970s — in two fascinating interviews.
Watch for All the Exciting Details
And Latest Market Insights…
With gold renewing its historic bull run at this moment… and with Empress Royalty (EMPR.V; EMPYF.OTCQX) perfectly positioned to leverage that move… the time to learn more is now.
Click on the video links below to get these valuable insights from Rick Rule and Money Metals CEO Stefan Gleason.
CLICK HERE
To Learn More About Empress RoyaltyCLICK BELOW
To Watch the Interviews With
Stefan Gleason and Rick Rule
Warnings and Disclaimers: As you know, every investment entails risk. Golden Opportunities hasn’t researched and cannot assess the suitability of any investments mentioned or advertised by our advertisers. We recommend you conduct your own due diligence and consult with your financial adviser before entering into any type of financial investment. This profile should be viewed as a paid advertisement. The publisher and staff of this publication may hold positions in the securities of companies discussed or recommended. The information contained herein has been received from sources which the publisher deems reliable. However, the publisher cannot guarantee that such information is complete and true in all respects. The advertiser provided a review of the factual content of this advertisement at the time of publication. The publisher is not a registered investment adviser and does not purport to offer personalized investment related advice; the publisher does not determine the suitability of advice and recommendations contained herein for any reader. Each person must separately determine whether such advice and recommendations are suitable and whether they fit within such person’s goals and portfolio. The advertiser featured in this edition of Golden Opportunities has paid the publisher for the costs and compensation related to the authorship, overhead, design and distributing this online edition, in the amount of $7,000. The publisher may receive revenue, the amount of which cannot be predetermined, from sales resulting from any accompanying offer. Authors of articles contained herein may have been compensated for their services in preparing such articles.
The information presented here is for general educational purposes only. You should always consult with your personal physician regarding any personal health problem, and you should always consult with your financial adviser regarding investment decisions. FDA DISCLOSURE: The statements, articles, and products featured in Headline Wealth emails and at HeadlineWealth.com have not been evaluated by the Food and Drug Administration. No information or products appearing in emails or the website are intended to diagnose, treat, cure, or prevent any disease. MATERIAL CONNECTION DISCLOSURE: Headline Wealth may have an affiliate relationship and/or another material connection to any persons or businesses mentioned in or linked to from emails or the website and may receive commissions from purchases you make on subsequent web sites. You should not rely solely on information published by Headline Wealth to evaluate the product or service being offered. Always exercise your own due diligence before purchasing any product or service.
HEADLINE WEALTH • PO BOX 49043 • CHARLOTTE, NC 28277